ITeos Therapeutics Inc (NAS:ITOS)
$ 18.03 -0.06 (-0.33%) Market Cap: 651.30 Mil Enterprise Value: 210.14 Mil PE Ratio: 0 PB Ratio: 1.20 GF Score: 40/100

Q2 2021 Iteos Therapeutics Inc Earnings Call Transcript

Aug 12, 2021 / 12:00PM GMT
Release Date Price: $24.91 (-0.44%)
Operator

Good morning, and welcome to the iTeos Therapeutics second-quarter 2021 financial results conference call. My name is Emily, and I will be your moderator today. (Operator Instructions) Please be advised that this call is being recorded at the company's request.

I would now like to turn the call over to Ryan Baker, Head of Investor Relations at iTeos. Please proceed.

Ryan Baker
iTeos Therapeutics, Inc. - IR

Thank you for joining us today. Joining me from iTeos with prepared remarks are Michel Detheux, President and CEO; and Matthew Gall, Chief Financial Officer; Dr. Joanne Lager, Chief Medical Officer, will be available for Q&A.

Before we begin, I would like to remind you all that the team will be making forward-looking statements in the prepared remarks and during the Q&A session. Any statements made during this call that are not statements of historical or current facts are intended to be forward-looking statements pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995.

We want to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot